Monday 28 January 2013

EACPT Geneva 2013: Symposium on Predictive Pharmacogenetics

-->
Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.
Symposium on Predictive Pharmacogenetics
In current clinical practice, the majority of drugs are given at a standardized dose that is sometimes followed by individual titration according to the physician’s experience, and to the patient’s related disease conditions, co-morbidities and co-medications. The knowledge of genetic modulation of therapeutic targets and of metabolism and transport of drugs has increased over the last decade so that individualized therapy adjusted to the patient’s genetic background has moved closer to reality. This session will be devoted to examine, with two outstanding experts, the validity of this issue in psychiatric and cardiovascular diseases, two main therapeutic challenges for the forthcoming century.
2013 EACPT Congress
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.
EACPT Geneva 2013 Congress website  www.eacpt2013.org

No comments:

Post a Comment